Full-length genome sequences of hepatitis C virus subtype 4f

Journal of General Virology

Volumn 88, Issue 11, 2007, Pages 2985-2990

  Hmaied, Fatma ^a,c   Legrand Abravanel, Florence ^a,b,c   Nicot, Florence ^a,b,c   Garrigues, Natalie ^c   Chapuy Regaud, Sabine ^a,b,c   Dubois, Martine ^a,b   Njouom, Richard ^a,c,d   Izopet, Jacques ^a,b,c   Pasquier, Christophe ^a,b,c  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d CENTRE PASTEUR DU CAMEROUN   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

5' UNTRANSLATED REGION; ARTICLE; CENTRAL AFRICA; CHEMOSENSITIVITY; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC RECOMBINATION; GENOTYPE; HEPATITIS C VIRUS; MIDDLE EAST; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENY; PRIORITY JOURNAL; SOUTHERN EUROPE; VIRUS CLASSIFICATION; VIRUS GENOME; VIRUS STRAIN;

5' UNTRANSLATED REGIONS; BASE SEQUENCE; GENOME, VIRAL; HEPACIVIRUS; HEPATITIS C; HUMANS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY;

HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 4; HEPATITIS C VIRUS SUBTYPE 4F;

EID: 36248953260     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83151-0     Document Type: Article

References (36)

1. Basso, M., Torre, F., Grasso, A., Percario, G., Azzola, E., Artioli, S., Bianchi, S., Pelli, N. & Picciotto, A. (2007). Pegylated interferon and ribavirin in re-treatment of responder-relapser HCV patients. Dig Liver Dis 39, 47-51.
2. Cenci, M., Massi, M., Alderisio, M., De Soccio, G. & Recchia, O. (2007). Prevalence of hepatitis C virus (HCV) genotypes and increase of type 4 in central Italy: an update and report of a new method of HCV genotyping. Anticancer Res 27, 1219-1222.
3. Chamberlain, R. W., Adams, N., Saeed, A. A., Simmonds, P. & Elliott, R. M. (1997). Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol 78, 1341-1347.
4. Derbala, M., Am, A., Bener, A., Lopez, A. C., Omar, M. & El Ghannam, M. (2005). Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis. J Viral Hepat 12, 380-385.
5. Franco, S., Tural, C., Clotet B. & Martinez, M. A. (2007). Complete nucleotide sequence of genotype 4 hepatitis C viruses isolated from patients co-infected with human immunodeficiency virus type 1. Virus Res 123, 161-169.
6. Fretz, C., Jeannel, D., Stuyver, L., Herve, V., Lunel, F., Boudifa, A., Mathiot, C., de The, G. & Fournel, J. J. (1995). HCV infection in a rural population of the Central African Republic (CAR): evidence for three additional subtypes of genotype 4. J Med Virol 47, 435-437.
7. Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Goncales, F. L., Jr, Haussinger, D., Diago, M., Carosi, G. & other authors (2002). Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347, 975-982.
8. Genovese, D., Dettorl, S., Argentini, C., Villano, U., Chionne, P., Angelico, M. & Rapicetta, M. (2005). Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis. J Clin Microbiol 43, 1902-1909.
9. Hasan, F., Asker, H., Al-Khaldi, J., Siddique, I., Al-Ajmi, M., Owaid, S., Varghese, R. & Al-Nakib, B. (2004). Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4. Am J Gastroenterol 99, 1733-1737.
10. Kumar, S., Tamura, K. & Nei, M. (2004). MEGA3: integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 5, 150-163.
11. Lauer, G. M. & Walker, B. D. (2001). Hepatitis C virus infection. N Engl J Med 345, 41-52.
12. Legrand-Abravanel, F., Nicot F., Boulestin, A., Sandres-Saune, K., Vinel, J. P., Alric, L. & Izopet, J. (2005). Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection. J Med Virol 77, 66-69.
13. Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K, Ling, M. & Albrecht J. K. (2001). Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358, 958-965.
14. Martin, D. P., Williamson, C. & Posada, D. (2005). RDP2: recombination detection and analysis from sequence alignments. Bioinformatics 21, 260-262.
15. Mellor, J., Holmes, E. C., Jarvis, L. M., Yap, P. L. & Simmonds, P. (1995). Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol 76, 2493-2507.
16. Miller, M. J. & Powell, J. I. (1994). A quantitative comparison of DNA sequence assembly programs. J Comput Biol 1, 257-269.
17. Morice, Y., Roulot D., Grando, V., Stirnemann, J., Gault E., Jeantils, V., Bentata, M., Jarrousse, B., Lortholary, O. & other authors (2001). Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. J Gen Virol 82, 1001-1012.
18. Nguyen, M. H. & Keeffe, E. B. (2005). Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clin Gastroenterol Hepatol 3, S97-S101.
19. Nicot, F., Legrand-Abravanel, F., Sandres-Saune, K., Boulestin, A., Dubois, M., Alric, L., Vinel, J. P., Pasquier, C. & Izopet, J. (2005). Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France. J Gen Virol 86, 107-114.
20. Njouom, R., Pasquier, C., Ayouba, A., Gessain, A., Froment, A., Mfoupouendoun, J., Pouillot R., Dubois, M., Sandres-Saune, K. & other authors (2003). High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J Med Virol 71, 219-225.
21. Page, R. D. M. (1996). TREEVIEW: An application to display phylogenetic trees on personal computers. Comput Appl Biosci 12, 357-358.
22. Pasquier, C., Njouom, R., Ayouba, A., Dubois, M., Sartre, M. T., Vessiere, A., Timba, I., Thonnon, J., Izopet, J. & Nerrienet, E. (2005). Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon. J Med Virol 77, 390-398.
23. Ray, S. C., Arthur, R. R., Carella, A., Bukh, J. & Thomas, D. L. (2000). Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182, 698-707.
24. Ray Kim, W. (2002). Global epidemiology and burden of hepatitis C. Microbes Infect 4, 1219-1225.
25. Robertson, B., Myers, G., Howard, C., Brettin, T., Bukh, J., Gaschen, B., Gojobori, T., Maertens, G., Mizokami, M. & other authors (1998). Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. international Committee on Virus Taxonomy. Arch Virol 143, 2493-2503.
26. Salemi, M. & Vandamme, A. M. (2002). Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences. J Mol Evol 54, 62-70.
27. Sandres-Saune, K, Deny, P., Pasquier, C., Thibaut, V., Duverlie, G. & Izopet, J. (2003). Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods 109, 187-193.
28. Schroter, M., Feucht, H. H., Zollner, B., Schafer, P. & Laufs, R. (2003). Multiple infections with different HCV genotypes: prevalence and clinical impact. J Clin Virol 27, 200-204.
29. Sharara, A. I., Ramia, S., Ramlawi, F., Fares, J. E., Klayme, S. & Naman, R. (2007). Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other Middle Eastern countries. Epidemiol Infect 135, 427-432.
30. Simmonds, P., Bukh, J., Combat, C., Deleage, G., Enomoto, N., Feinstone, S., Halfon, P., Inchauspe, G., Kuiken, C. & other authors (2005). Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42, 962-973.
31. Thompson, J. D., Higgins, D. G. & Gibson, T. J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673-4680.
32. Timm, J., Neukamm, M., Kuntzen, T., Kim, A. Y., Chung, R. T., Brander, C., Lauer, G. M., Walker, B. D. & Allen, T. M. (2007). Characterization of full-length hepatitis C virus genotype 4 sequences. J Viral Hepat 14, 330-337.
33. van Asten, L., Verhaest, I., Lamzira, S., Hernandez-Aguado, I., Zangerle, R., Boufassa, F., Rezza, G., Broers, B., Robertson, J. R. & other authors (2004). Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis 189, 292-302.
34. Wohnsland, A., Hofmann, W. P. & Sarrazin, C. (2007). Viral determinants of resistance to treatment in patients with hepatitis C. Clin Microbiol Rev 20, 23-38.
35. Xu, L. Z., Larzul, D., Delaporte, E., Brechot, C. & Kremsdorf, D. (1994). Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). J Gen Virol 75, 2393-2398.
36. Zeuzem, S., Hultcrantz, R., Bourliere, M., Goeser, T., Marcellin, P., Sanchez-Tapias, J., Sarrazin, C., Harvey, J., Brass, C. & Albrecht J. (2004). Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3. J Hepatol 40, 993-999.